What is pharmacogenomics?

From Pharmacogenomics.org

Revision as of 08:40, 2 April 2009 by WikiSysop (Talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Pharmacogenomics is the branch of pharmacology and genomics that deals with the influence of genetic variation on drug response in patients by correlating molecular expressions and single-nucleotide polymorphisms with a drug's efficacy or toxicity. 

Pharmacogenomics aims to develop rational means to optimise drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Such approaches promise the advent of "personalized medicine"; in which drugs and drug combinations are optimized for each individual's unique genetic makeup.[1]

Pharmacogenomics is the whole genome application of pharmacogenetics, which examines the single gene interactions with drugs.

 

References

  1. ^ "Guidance for Industry Pharmacogenomic Data Submissions" (PDF). U.S. Food and Drug Administration. March 2005. http://www.fda.gov/cder/guidance/6400fnl.pdf. Retrieved on 2008-08-27. 

Pharmacogenomics is the study of a patient's genes to predict response to drugs and hence select the right drug and the right quantity.

 

See also

  • Genomics
    • Chemogenomics
    • Structural genomics
    • Pharmacogenetics
    • Toxicogenomics
    • Clinomics
    • p450

  • Pharmaceutical company

External links

Personal tools